XML 39 R21.htm IDEA: XBRL DOCUMENT
v3.25.3

Business Segments | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Business Segments | Note 12—Business Segments Globe Life is organized into three operating segments: life, health, and investments. Globe Life's reportable insurance segments are based on the insurance product lines it markets and administers: life insurance and supplemental health insurance. There is also an investment segment that manages the investment portfolio and cash flow for the insurance segments. The Company's chief operating decision makers ("CODM"), our Co-CEOs, evaluate the overall performance of the operations of the Company in accordance with these segments. During the fourth quarter of 2024 we entered into a coinsurance agreement to cede a majority of the annuity business to a third-party insurer. This impacted a significant portion of our annuities which had previously been classified as one of our reportable segments. The annuity segment has historically represented less than 1% of revenue and has not been core to the Company's business. We adjusted our segments from four down to three at December 31, 2024. All quarterly presentations of segment information related to prior year have been recast for the periods presented to reflect this change in segments. Life insurance products marketed by Globe Life include traditional whole life and term life insurance. Health insurance products are generally guaranteed renewable and include Medicare Supplement, cancer, critical illness, accident, and other limited-benefit supplemental hospital and surgical products. The Company adopted ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in 2024 which added disclosure requirements to segment expenses, improving the financial reporting of the entity’s overall performance and assessment of future cash flows. The disclosures required more detailed information related to the entity’s reportable segments and the new disclosures are also required prospectively on a quarterly basis. The prior-year presentation has been recast to reflect the new disclosures in accordance with this adopted accounting standard. The following tables present segment premium revenue by each of Globe Life's distribution channels.
|  | Premium Income by Distribution Channel
|  | Three Months Ended September 30, 2025
|  | Life |  | Health |  |  |  | Total
Distribution Channel |  | Amount |  | % of Total |  | Amount |  | % of Total |  |  |  |  |  | Amount |  | % of Total
American Income |  | $ | 451,214 |  |  | 53 |  |  | $ | 31,693 |  |  | 8 |  |  |  |  |  |  | $ | 482,907 |  |  | 39 |
Direct to Consumer |  | 244,828 |  |  | 29 |  |  | 19,186 |  |  | 5 |  |  |  |  |  |  | 264,014 |  |  | 21 |
Liberty National |  | 98,190 |  |  | 12 |  |  | 47,270 |  |  | 12 |  |  |  |  |  |  | 145,460 |  |  | 12 |
United American |  | 1,542 |  |  | — |  |  | 169,735 |  |  | 44 |  |  |  |  |  |  | 171,277 |  |  | 14 |
Family Heritage |  | 1,896 |  |  | — |  |  | 118,640 |  |  | 31 |  |  |  |  |  |  | 120,536 |  |  | 10 |
Other |  | 46,813 |  |  | 6 |  |  | — |  |  | — |  |  |  |  |  |  | 46,813 |  |  | 4 |
Total |  | $ | 844,483 |  |  | 100 |  |  | $ | 386,524 |  |  | 100 |  |  |  |  |  |  | $ | 1,231,007 |  |  | 100 |
|  | Premium Income by Distribution Channel
|  | Three Months Ended September 30, 2024
|  | Life |  | Health |  |  |  | Total
Distribution Channel |  | Amount |  | % of Total |  | Amount |  | % of Total |  |  |  |  |  | Amount |  | % of Total
American Income |  | $ | 427,839 |  |  | 52 |  |  | $ | 31,277 |  |  | 9 |  |  |  |  |  |  | $ | 459,116 |  |  | 39 |
Direct to Consumer |  | 246,425 |  |  | 30 |  |  | 18,072 |  |  | 5 |  |  |  |  |  |  | 264,497 |  |  | 23 |
Liberty National |  | 93,625 |  |  | 12 |  |  | 47,277 |  |  | 13 |  |  |  |  |  |  | 140,902 |  |  | 12 |
United American |  | 1,608 |  |  | — |  |  | 149,510 |  |  | 42 |  |  |  |  |  |  | 151,118 |  |  | 13 |
Family Heritage |  | 1,684 |  |  | — |  |  | 107,819 |  |  | 31 |  |  |  |  |  |  | 109,503 |  |  | 9 |
Other |  | 47,457 |  |  | 6 |  |  | — |  |  | — |  |  |  |  |  |  | 47,457 |  |  | 4 |
Total |  | $ | 818,638 |  |  | 100 |  |  | $ | 353,955 |  |  | 100 |  |  |  |  |  |  | $ | 1,172,593 |  |  | 100 |
|  | Nine Months Ended September 30, 2025
|  | Life |  | Health |  |  |  | Total
Distribution Channel |  | Amount |  | % of Total |  | Amount |  | % of Total |  |  |  |  |  | Amount |  | % of Total
American Income |  | $ | 1,334,591 |  |  | 53 |  |  | $ | 93,806 |  |  | 8 |  |  |  |  |  |  | $ | 1,428,397 |  |  | 39 |
Direct to Consumer |  | 736,651 |  |  | 29 |  |  | 57,374 |  |  | 5 |  |  |  |  |  |  | 794,025 |  |  | 22 |
Liberty National |  | 291,635 |  |  | 12 |  |  | 142,823 |  |  | 13 |  |  |  |  |  |  | 434,458 |  |  | 12 |
United American |  | 4,704 |  |  | — |  |  | 493,561 |  |  | 43 |  |  |  |  |  |  | 498,265 |  |  | 14 |
Family Heritage |  | 5,418 |  |  | — |  |  | 346,850 |  |  | 31 |  |  |  |  |  |  | 352,268 |  |  | 9 |
Other |  | 140,891 |  |  | 6 |  |  | — |  |  | — |  |  |  |  |  |  | 140,891 |  |  | 4 |
Total |  | $ | 2,513,890 |  |  | 100 |  |  | $ | 1,134,414 |  |  | 100 |  |  |  |  |  |  | $ | 3,648,304 |  |  | 100 |
|  | Nine Months Ended September 30, 2024
|  | Life |  | Health |  |  |  | Total
Distribution Channel |  | Amount |  | % of Total |  | Amount |  | % of Total |  |  |  |  |  | Amount |  | % of Total
American Income |  | $ | 1,265,417 |  |  | 52 |  |  | $ | 92,495 |  |  | 9 |  |  |  |  |  |  | $ | 1,357,912 |  |  | 39 |
Direct to Consumer |  | 743,304 |  |  | 31 |  |  | 54,070 |  |  | 5 |  |  |  |  |  |  | 797,374 |  |  | 23 |
Liberty National |  | 276,599 |  |  | 11 |  |  | 142,612 |  |  | 14 |  |  |  |  |  |  | 419,211 |  |  | 12 |
United American |  | 5,009 |  |  | — |  |  | 440,375 |  |  | 42 |  |  |  |  |  |  | 445,384 |  |  | 13 |
Family Heritage |  | 4,945 |  |  | — |  |  | 317,065 |  |  | 30 |  |  |  |  |  |  | 322,010 |  |  | 9 |
Other |  | 143,111 |  |  | 6 |  |  | — |  |  | — |  |  |  |  |  |  | 143,111 |  |  | 4 |
Total |  | $ | 2,438,385 |  |  | 100 |  |  | $ | 1,046,617 |  |  | 100 |  |  |  |  |  |  | $ | 3,485,002 |  |  | 100 |
Due to the nature of the life insurance industry, Globe Life has no individual or group that would be considered a major customer. Substantially all of Globe Life's business is conducted in the United States. The measure of profitability established by the CODM for the insurance segments is underwriting margin before other income and administrative expenses, in accordance with the manner in which the segments are managed. It essentially represents gross profit margin on insurance products before insurance administrative expenses and consists primarily of premium less net policy benefits, acquisition expenses, and commissions. Required interest on policy liabilities is reflected as a component of the Investment segment (rather than as a component of underwriting margin in the insurance segment) in order to match this cost with the investment income earned on the assets supporting the policy liabilities. The measure of profitability for the Investment segment is excess investment income, representing the net income earned on the investment portfolio in excess of policy requirements. Other than the required interest on the insurance segments, no other intersegment revenues or expenses are recognized. Expenses directly attributable to corporate operations are included in the “Corporate & Other” category. Stock-based compensation expense is considered a corporate expense by Globe Life management and is included in this category. All other unallocated revenues and expenses on a pretax basis, including insurance administrative expense and interest on debt, are also included in the “Corporate & Other” segment category. Globe Life holds a sizable investment portfolio to support its insurance liabilities, the yield from which is used to offset policy benefit, acquisition, administrative, and tax expenses. This yield or investment income is taken into account when establishing premium rates and profitability expectations for its insurance products. From time to time, investments are sold or called, or experience a credit loss event, each of which are reflected by the Company as realized gain (loss)—investments. These gains or losses generally occur as a result of disposition due to issuer calls, compliance with Company investment policies, or other reasons often beyond management’s control. Unlike investment income, realized gains and losses are incidental to insurance operations, and only overall yields are considered when setting premium rates or insurance product profitability expectations. While these gains and losses are not relevant to segment profitability or core operating results, they can have a material positive or negative result on net income. For these reasons, management removes realized investment gains and losses when it views its segment operations. Management also removes non-operating items unrelated to the Company's core insurance activities when evaluating those results. Therefore, these items are excluded in its presentation of segment results because accounting guidance requires that operating segment results be presented as management views its business. All of these items are included in “Other operating expense” in the Condensed Consolidated Statements of Operations for the appropriate year. See additional detail below in the tables. The following tables set forth a reconciliation of Globe Life's revenues and operations by segment to its major income statement line items. See Note 1—Significant Accounting Policies for additional information concerning reconciling items of segment profits to pretax income.
| Three Months Ended September 30, 2025
| Life |  | Health |  | Investment |  | Consolidated
Revenue: |  |  |  |  |  |  |
Premium | $ | 844,483 |  |  | $ | 386,524 |  |  | $ | — |  |  | $ | 1,231,007 |
Net investment income | — |  |  | — |  |  | 286,013 |  |  | 286,013 |
Segment revenue | 844,483 |  |  | 386,524 |  |  | 286,013 |  |  | 1,517,020 |
Realized gains (losses) |  | (4,987) |
Other income |  | 955 |
Total consolidated revenue |  | $ | 1,512,988 |
Expenses: |  |  |  |  |  |  |
Policy obligations(1) | 381,511 |  |  | 227,940 |  |  | 5,787 |  |  | 615,238 |
Required interest on reserves | (212,454) |  |  | (28,517) |  |  | 243,343 |  |  | 2,372 |
Amortization of acquisition costs | 98,583 |  |  | 15,137 |  |  | — |  |  | 113,720 |
Commissions | 42,924 |  |  | 42,699 |  |  | — |  |  | 85,623 |
Premium taxes | 16,928 |  |  | 7,281 |  |  | — |  |  | 24,209 |
Non-deferred acquisition costs | 35,383 |  |  | 13,610 |  |  | — |  |  | 48,993 |
Segment profit or (loss) | $ | 481,608 |  |  | $ | 108,374 |  |  | $ | 36,883 |  |  | 626,865 |
Insurance administrative expenses: |  |  |  |  |  |  |
Salaries |  | 34,265 |
Other employee costs |  | 10,056 |
Information technology costs |  | 21,795 |
Legal costs |  | 4,854 |
Other administrative costs |  | 18,797 |
Parent expense |  | 4,105 |
Stock-based compensation expense |  | 14,603 |
Interest expense |  | 36,134 |
Legal proceedings |  | 2,589 |
Other expenses |  | 498 |
Annuity |  | (1,965) |
Total expenses |  | 1,035,886 |
Income before income taxes per Condensed Consolidated Statements of Operations | $ | 477,102 |
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
| Three Months Ended September 30, 2024
| Life |  | Health |  | Investment |  | Consolidated
Revenue: |  |  |  |  |  |  |
Premium | $ | 818,638 |  |  | $ | 353,955 |  |  | $ | — |  |  | $ | 1,172,593 |
Net investment income | — |  |  | — |  |  | 284,964 |  |  | 284,964 |
Segment revenue | 818,638 |  |  | 353,955 |  |  | 284,964 |  |  | 1,457,557 |
Realized gains (losses) |  | (2,192) |
Other income |  | 42 |
Total consolidated revenue |  | 1,455,407 |
Expenses: |  |  |  |  |  |  |
Policy obligations(1) | 454,502 |  |  | 221,926 |  |  | 6,040 |  |  | 682,468 |
Required interest on reserves | (203,875) |  |  | (27,717) |  |  | 239,421 |  |  | 7,829 |
Amortization of acquisition costs | 90,070 |  |  | 13,852 |  |  | — |  |  | 103,922 |
Commissions | 40,092 |  |  | 36,963 |  |  | — |  |  | 77,055 |
Premium taxes | 16,968 |  |  | 9,131 |  |  | — |  |  | 26,099 |
Non-deferred acquisition costs | 33,698 |  |  | 12,837 |  |  | — |  |  | 46,535 |
Segment profit or (loss) | $ | 387,183 |  |  | $ | 86,963 |  |  | $ | 39,503 |  |  | 513,649 |
Insurance administrative expenses: |  |  |  |  |  |  |
Salaries |  | 33,377 |
Other employee costs |  | 10,455 |
Information technology costs |  | 20,155 |
Legal costs |  | 7,609 |
Other administrative costs |  | 16,869 |
Parent expense |  | 3,210 |
Stock-based compensation expense |  | 9,233 |
Interest expense |  | 31,388 |
Legal proceedings |  | 3,329 |
Other expenses |  | 637 |
Annuity |  | (1,721) |
Total expenses |  | 1,078,449 |
Income before income taxes per Condensed Consolidated Statements of Operations | $ | 376,958 |
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
| Nine Months Ended September 30, 2025
| Life |  | Health |  | Investment |  | Consolidated
Revenue: |  |  |  |  |  |  |
Premium | $ | 2,513,890 |  |  | $ | 1,134,414 |  |  | $ | — |  |  | $ | 3,648,304 |
Net investment income | — |  |  | — |  |  | 848,796 |  |  | 848,796 |
Segment revenue | 2,513,890 |  |  | 1,134,414 |  |  | 848,796 |  |  | 4,497,100 |
Realized gains (losses) |  | (23,476) |
Other income |  | 1,073 |
Total consolidated revenue |  | $ | 4,474,697 |
Expenses: |  |  |  |  |  |  |
Policy obligations(1) | 1,410,622 |  |  | 691,793 |  |  | 16,591 |  |  | 2,119,006 |
Required interest on reserves | (632,150) |  |  | (85,194) |  |  | 724,624 |  |  | 7,280 |
Amortization of acquisition costs | 285,417 |  |  | 44,497 |  |  | — |  |  | 329,914 |
Commissions | 130,848 |  |  | 127,551 |  |  | — |  |  | 258,399 |
Premium taxes | 51,621 |  |  | 22,423 |  |  | — |  |  | 74,044 |
Non-deferred acquisition costs | 108,586 |  |  | 42,192 |  |  | — |  |  | 150,778 |
Segment profit or (loss) | $ | 1,158,946 |  |  | $ | 291,152 |  |  | $ | 107,581 |  |  | 1,557,679 |
Insurance administrative expenses: |  |  |  |  |  |  |
Salaries |  | 102,630 |
Other employee costs |  | 29,764 |
Information technology costs |  | 62,286 |
Legal costs |  | 16,930 |
Other administrative costs |  | 51,753 |
Parent expense |  | 10,710 |
Stock-based compensation expense |  | 40,665 |
Interest expense |  | 106,011 |
Legal proceedings |  | 13,365 |
Other expenses |  | 498 |
Annuity |  | (5,818) |
Total expenses |  | 3,368,215 |
Income before income taxes per Condensed Consolidated Statement of Operations |  | $ | 1,106,482 |
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities.
| Nine Months Ended September 30, 2024
| Life |  | Health |  | Investment |  | Consolidated
Revenue: |  |  |  |  |  |  |
Premium | $ | 2,438,385 |  |  | $ | 1,046,617 |  |  | $ | — |  |  | $ | 3,485,002 |
Net investment income | — |  |  | — |  |  | 853,178 |  |  | 853,178 |
Segment revenue | 2,438,385 |  |  | 1,046,617 |  |  | 853,178 |  |  | 4,338,180 |
Realized gains (losses) |  | (26,580) |
Other income |  | 192 |
Total consolidated revenue |  | $ | 4,311,792 |
Expenses: |  |  |  |  |  |  |
Policy obligations(1) | 1,493,165 |  |  | 629,676 |  |  | 15,044 |  |  | $ | 2,137,885 |
Required interest on reserves | (605,397) |  |  | (82,300) |  |  | 712,055 |  |  | 24,358 |
Amortization of acquisition costs | 263,753 |  |  | 40,774 |  |  | — |  |  | 304,527 |
Commissions | 118,480 |  |  | 117,773 |  |  | — |  |  | 236,253 |
Premium taxes | 51,254 |  |  | 21,221 |  |  | — |  |  | 72,475 |
Non-deferred acquisition costs | 100,613 |  |  | 38,252 |  |  | — |  |  | 138,865 |
Segment profit or (loss) | $ | 1,016,517 |  |  | $ | 281,221 |  |  | $ | 126,079 |  |  | 1,423,817 |
Insurance administrative expenses: |  |  |  |  |  |  |
Salaries |  | 95,406 |
Other employee costs |  | 28,531 |
Information technology costs |  | 59,023 |
Legal costs |  | 19,771 |
Other administrative costs |  | 48,341 |
Parent expense |  | 9,166 |
Stock-based compensation expense |  | 28,590 |
Interest expense |  | 91,413 |
Legal proceedings |  | 5,764 |
Other expenses |  | 2,604 |
Annuity |  | (5,384) |
Total expenses |  | 3,297,588 |
Income before income taxes per Condensed Consolidated Statement of Operations |  | $ | 1,014,204 |
(1)Policy obligations are based upon policyholder behavior and impacts related to lapses, mortality, and morbidity. For detailed information, including remeasurement gains and losses, see Note 6—Policy Liabilities. Assets for each segment are reported based on a specific identification basis. The insurance segments’ assets contain DAC. The investment segment includes the investment portfolio, cash, and accrued investment income. Goodwill is assigned to the insurance segments at the time of purchase. All other assets are included in the annuity and other corporate category. The tables below reconcile segment assets to total assets as reported on the Condensed Consolidated Balance Sheets. Assets by Segment
| September 30, 2025
| Life |  | Health |  | Investment |  | Consolidated
Cash and invested assets | $ | — |  |  | $ | — |  |  | $ | 20,629,430 |  |  | $ | 20,629,430 |
Accrued investment income | — |  |  | — |  |  | 284,888 |  |  | 284,888 |
Deferred acquisition costs | 6,035,556 |  |  | 836,449 |  |  | — |  |  | 6,872,005 |
Goodwill | 309,609 |  |  | 180,837 |  |  | — |  |  | 490,446 |
Total segment assets | $ | 6,345,165 |  |  | $ | 1,017,286 |  |  | $ | 20,914,318 |  |  | 28,276,769 |
Annuity and other corporate |  | 2,250,847 |
Total assets |  | $ | 30,527,616 |
| December 31, 2024
| Life |  | Health |  | Investment |  | Consolidated
Cash and invested assets | $ | — |  |  | $ | — |  |  | $ | 19,736,888 |  |  | $ | 19,736,888 |
Accrued investment income | — |  |  | — |  |  | 269,791 |  |  | 269,791 |
Deferred acquisition costs | 5,700,755 |  |  | 793,421 |  |  | — |  |  | 6,494,176 |
Goodwill | 309,609 |  |  | 180,837 |  |  | — |  |  | 490,446 |
Total segment assets | $ | 6,010,364 |  |  | $ | 974,258 |  |  | $ | 20,006,679 |  |  | 26,991,301 |
Annuity and other corporate |  | 2,084,880 |
Total assets |  | $ | 29,076,181 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration